Cambridge Investment Research Advisors, Inc. Caribou Biosciences, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.6 Billion
- Q1 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 612,412 shares of CRBU stock, worth $471,557. This represents 0.0% of its overall portfolio holdings.
Number of Shares
612,412Holding current value
$471,557% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CRBU
# of Institutions
140Shares Held
55.5MCall Options Held
21.2KPut Options Held
96.4K-
Black Rock Inc. New York, NY6.95MShares$5.35 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.57MShares$3.52 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.88MShares$2.98 Million0.4% of portfolio
-
Morgan Stanley New York, NY2.75MShares$2.12 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.5MShares$1.92 Million0.0% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $46.8M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...